Long-Chain Non-Coding RNA SNHG3 Promotes the Growth of Ovarian Cancer Cells by Targeting miR-339-5p/TRPC3 Axis
Authors:
Open Access
- 1 October 2020
- journal article
- research article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 13, 10959-10971
Abstract
Background: Long-chain non-coding RNA (lncRNA) small nucleolar RNA host gene 3 (SNHG3) is reportedly overexpressed in malignant tumors, but its regulatory role in human ovarian cancer (OC) is not fully understood. Methods: A qRT-PCR assay was carried out to detect the level of SNHG3 in OC tissues, serum and cells, a CCK-8 assay to measure the proliferation of OC cells, a transwell assay to measure the invasion and migration of OC cells, and a flow cytometry to detect the cell cycle distribution and apoptosis rate of OC cells. In addition, in vivo experiment was also conducted to determine the effect of SNHG3 on the growth of OC cells. Results: SNHG3 was overexpressed in OC tissues, serum, and cells, and the overexpression in serum indicated a poor prognosis of patients. It was also found that knockdown of SNHG3 could inhibit the malignant phenotypes of OC cells, cause G1/G0 cell cycle arrest, and intensify apoptosis. Furthermore, in in vitro experiments, the growth ability of OC cells was inhibited under knockdown of SNHG3. Assays for relationship verification showed that SNHG3 regulated the expression of miR-339-5p and the canonical transient receptor potential 3 (TRPC3), and the rescue experiment revealed that co-transfection of si-SNHG3+miR-339-5p-inhibitor or si-SNHG3+pcDNA3.1-TRPC3 could reverse the effects of knockdown of SNHG3 on the biological behavior of OC cells. Conclusion: SNHG3 can be adopted as a marker for diagnosis and prognosis evaluation of OC and it plays a role in the progression of OC by enabling the miR-339-5p sponge to regulate TRPC3 expression.Keywords
This publication has 38 references indexed in Scilit:
- Circulating biomarkers in epithelial ovarian cancer diagnosis: from present to future perspectiveAnnals of Translational Medicine, 2017
- Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)Gynecologic Oncology, 2017
- LncRNAs expression profiling in normal ovary, benign ovarian cyst and malignant epithelial ovarian cancerScientific Reports, 2016
- MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cellsJournal of Experimental & Clinical Cancer Research, 2016
- SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinomaTumor Biology, 2015
- MicroRNA expression profiling and functional annotation analysis of their targets associated with the malignant transformation of oral leukoplakiaGene, 2015
- Transient receptor potential (TRP) channels, promising potential diagnostic and therapeutic tools for cancerBioScience Trends, 2014
- TRPC Channels and Their Splice Variants are Essential for Promoting Human Ovarian Cancer Cell Proliferation and TumorigenesisCurrent Cancer Drug Targets, 2013
- TRPC channels and their splice variants are essential for promoting human ovarian cancer cell proliferation and tumorigenesis.2013
- Transient receptor potential channel C3 contributes to the progression of human ovarian cancerOncogene, 2009